Genmab — August 2017
-
Mit bud på lukkekurs i dag er : 1475 kr
-
Ønsketænkning ? Så havde jeg skrevet 2475

-
Jeg kan huske dengang da der var rygter ude om at GS ville købe Genmab for kurs 300, ja endda helt oppe til 360. Dengang var stemning også helt euforisk her på chatten. I bag klog skabs lys var det godt at det kun var rygter, jeg tror også at aktionærene på den lange bane denne gang, også er bedst tjent med at det bliver ved rygter.
-
jamen så tager vi den igen, nu da MW er på banen http://medwatch.dk/Medicinal___Biotek/article9826468.ece
-
Takeda buys into Astrazeneca's early stage Parkinson's program - http://www.bioworld.com/content/takeda-buys-astrazenecas-early-stage-parkinsons-program
-
Det er sgu en sund premium, som Gilead betaler for Kite... (jvf artiklen)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
